Location: United States, California, La Jolla
Investors 1
| Date | Name | Website |
| - | Biobrit | biobrit.co... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 24.12.2021 | Biocon Ltd. - Clinical Study for Itolizumab in Lupus Nephrit... | Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), announced that U... | marketscre... |
| 11.06.2021 | EQUILLIUM, INC. Equillium : Announces Positive Topline Resu... | Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute... | marketscre... |
| 14.11.2018 | Can a 'rediscovered' drug from India make it big in US i... | Biotech companies typically knock on Nasdaq’s doors with several rounds of financing unde... | endpts.com... |